Early Discoveries in Protein a-N-Terminal Methylation
Emerging epigenetic modulators have continued to reshape our understanding of eukaryotic gene expression and regulation. Lysa nd Arg methylation are two well-known epigenetic marks that play important roles in regulating chromatin dynamics and transcription activation. Protein lysine methyltransferases( PKMTs) and arginine methyltransferases (PRMTs) catalyze the covalent addition of am ethyl group from S-adenosylmethionine (SAM) to the e-amino group of the Lyss ide chain and guanidino group of the Arg side chain, respectively (Scheme 1). After the methyl group is transferred, SAM is transformed into S-adenosylhomocysteine (SAH). Unlike PKMTsa nd PRMTst hat methylate the side chain, protein N-terminal methyltransferases (NTMTs) transfer am ethyl group to the a-amino group at the protein Nterminus. Although protein a-N-terminal methylation has been ak nown post-translationalm odification for over four decades, its emerging features have made it ar elatively new addition to thel ist of players in these processes.
Protein a-N-terminal methylation was initially discovered in Escherichia coli on ribosomal subunits, including methylalanine (MeAla)o nt he a-N terminus of L33 (MeAla-Lys-Gly) and S11 (MeAla-Lys-Ala), methylmethionine (MeMet) on L16 (MeMetLeu-Gln), over four decades ago. [1] [2] [3] Since then, many cases of a-N-terminal methylation have been reported on various proteins, such as dimethylproline (Me 2 Pro) on Crithidia oncopelti cytochrome ca nd Asterias rubens histone H2B, trimethylalanine (Me 3 Ala) on E. coli ribosomal protein L11, Tetrahymena histone 2B, and all vertebrate striated muscle light chains. [4] [5] [6] [7] Because the aforementioned protein substrates are componentso f macromolecular complexes, a-N-terminal methylation has been inferred to mediate protein-protein interactions. In addition, eukaryotic N-terminal methylated proteins werep ostulated to be involved in protein degradation on the basis that methylation might interfere with N-terminal acetylation. [8] However, knowledge of the physiological consequences of protein a-N-terminal methylation is still very limited. Recent identifications of eukaryotic protein a-NTMTsh ave prompted increasing discoverieso fn ew protein substrates; [9] [10] [11] [12] [13] thuss upporting that a-N-terminal methylation is aw idespreadp osttranslational modification.
Discovery of Protein NTMTs

Prokaryotic protein NTMT
Protein L11m ethyltransferase (PrmA)i sr esponsible for catalyzing a-N-terminal methylation of the bacterial 50S ribosomal subunit protein L11. [14, 15] It is conserved among bacteria, but absent from archaea. [16] PrmA is am ultifunctional methyltransferase (MTase) because it is able to modify both the a-N-terminal amine and e-aminog roups of two different Lysr esidues. [14, 16] PrmA consistso fa nN -terminal domain for substrate recognition,aC-terminal catalytic domain with as even-bstrand structural fold, and af lexible linker helix ( Figure 1A ). [17] Structurals tudies revealed aw ide range of domain movementso fP rmA,a se xemplified by the structure of PrmA boundt oL 11,i nc omparison witht he apo form of PrmA (Figure 1B) . [17] Such conformational changes are necessary for the recognition of multiple substrate sites. PrmA preferentially methylates free ribosomalp rotein L11o ver an assembled 50S ribosomals ubunit;t herefore, methylationo fL 11 mayf acilitate the assembly of the large subunit. [16] However,t he role of L11 methylation remains am ystery because mutants and deletion of PrmA show no growth defects or any distinct phenotype in E. coli and Thermus thermophilus. [15, 16] Investigationo ft hose strainsu nder different stress conditions may provide new insights into the function of N-terminal methylation of L11.
Eukaryotic proteinNTMTsthat methylate an X-P-K/R motif
Yeast YBR261C/Tae1 protein was identified ast he NTMT Ntm1 in Saccharomyces cerevisiae by Webb et al. in 2010. [11] YBR261C recognizes the canonical X-P-K recognition motif and methylates ribosomal substrates Rp112ab and Rps25a/Rps25b. Meanwhile, YBR261C is able to methylate nonamer syntheticp eptides, including PPKQQLSKY,w hich is derived from a-N-terminal Rps25a/b and A/S-PKQQLSKY,w ithA la or Ser replacing Protein a-N-terminal methylation is catalyzed by protein N-terminal methyltransferases. The prevalent occurrenceo ft his methylation in ribosomes, myosin, and histones implies its functioni np rotein-protein interactions.A lthough its full spectrum of function has not yet been outlined, recent discoveries have revealed the emerging roles of a-N-terminal methylation in protein-chromatin interactions, DNA damage repair,a nd Pro. [11] Previous chemical genetic profile analysisi ndicated that deletion of YBR261C in yeast abolished N-terminal methylation, which consequently alteredt he ribosomal profile and led to defects in both translational efficiency andf idelity. [11, 18] Overexpression of YBR261 validated its involvement in protein synthesis. [18] In addition, a-N-terminal methylation has been detected in the yeast Rpt1 (PPKEDW) subunit of the 19S regulatory particle of 26S proteasome. [19] If the PK sequence at the second and third positions wasd eleted from Rpt1, N-terminal methylation of Rpt1 was abolished. [19] With this PK deletion, yeast strains grow more slowly and are more sensitive to stress. [19] Despite the implications of a-N-terminal methylation of Rpt1 on cell growth and stress tolerance in yeast, [19] In 2012, dNTMT (CG1675) was identified as the enzyme for a-N-terminal methylation of H2Bp rotein in Drosophila melanogaster. [20] The N-terminal methylation levels of H2B were increasedd uring fly development and in the presence of cellular stress, such as heat and proliferation stress. [20] dNTMTw as mainly located in the nucleus, where the majority of chromatin-boundH 2B is methylated. [19] dNTMT recognizes the N-terminal sequence of D. melanogaster H2B (PPKTSG), which conforms to the canonical X-P-K recognition motif for its mammalian orthologs (X = A, P, or S). dNTMTmethylation is not processive since monomethylated Pro was accumulated during the methylation reaction. As equence search suggested about 36 proteins carrying a( M)-A/P/S-P-K recognition motif in the predicted proteome of D. melanogaster. [20] In addition, dART8, a PRMT for H3R2 methylation, negatively regulated H2B N-terminal methylation; [20] thussuggesting crosstalk betweenmethylation on two histone tails.
Webb et al. first identified the humanM ETTL11A/NTMT1e ncoded by the METTL11A gene, along with the discovery of YBR261C/TAE1. [11] Simultaneously,M acara et al. isolatedt he same protein from HeLa cell soluble nuclear extracts,a nd named it N-terminalR CC1 methyltransferase (NRMT1) on account of its substrate regulator of chromosome condensation 1 (RCC1). [10] The discovery of NTMT1/NRMT1 has led to rising reports on N-terminal methylation existing in tumor suppressor retinoblastoma 1( RB1), oncoprotein SET (also knowna s I2PP2A,T AF1a), damagedD NA-binding protein 2( DDB2), poly(ADP-ribose) polymerase 3( PARP3),a nd centromerep roteinsAa nd B( CENP-A&B,F igure2). [10, [21] [22] [23] [24] [25] Crystals tructureso f NTMT1i nc omplex with peptides ubstratesa nd SAHr evealed thes tructuralb asisf or thep referred recognitionm otif X-P-K/R (X canbeany aminoacid, except DorE). [26, 27] Substraterecognition is discussedi nm ored etaili nS ection 2.4. TheN TMT1 gene is expressedi na ll tissues, andt he proteini se xpressed in most tissues, except spleen,l iver,a nd fallopian tube tissue, according to the Human Protein Atlas (http://www.proteinatlas.org). Additionally, NTMT1 is overexpressed in tumor tissues of patients, including colorectal, melanoma, carcinoid, lung, and liver,a ccording to ProteinAtlas (http://www.proteinatlas.org). [28] Knockdown of NTMT1r esults in mitotic defects and sensitizes etoposide andg amma irradiation in breast cancerc ell lines such as MCF-7 and LCC9,w hereas NTMT1k nockout mice showed premature aging. [29, 30] Both studies infer the function of NTMT1i n DNA damage repair.
The NTMT1 homologue NTMT2/METTL11B shareso ver5 0% sequence similarity with NTMT1 ( Figure 3A) . [11] This homologue was suggested as another NTMT in 2010 and confirmed to be an NTMT by 2013. [9] Both NTMT1a nd NTMT2r ecognize an X-P-K/R consensus sequence, in which Xc an be any amino acid, except Do rE . [9-11, 26, 27, 31] Although NTMT2 was originally proposed to be am onomethylase, recent studies indicated that it could also fully methylate both GPKRIA and PPKRIA peptides. [9, 31] However,t he physiological substrate of NTMT2 remains to be uncovered. NTMT2i sp redominantly expressed in heart and skeletal muscle tissues, [28] whichs uggesting the possibility of its role in at issue-specific context. YBR261C and NTMT1/2 are able to methylate nona-and hexamer peptides, [11, 26, [31] [32] [33] respectively.I na ddition, eukaryotic protein NTMTss hare an X-P-K/R motif. Therefore, it is reasonable to speculate that an N-terminal linear sequence is sufficient for their recognition. Kinetic studies on protein substrates would shed light on how other sequences contribute to recognition and methylation transfer.
Eukaryotic proteinNTMTsthat methylate elongation factor 1A
In addition to a-N-terminal methylation on the classical X-P-K/ Rm otif in eukaryotic cells, an ovel N-terminal methylation has been recently reported on eukaryotic elongation factor 1A (eEF1A) in both yeast and humans. [12, 13] YLR285W, also named elongation factor methyltransferase 7( Efm7), is ad ual MTase that installs methyl groups at both N-terminal Gly1 and Lys2 residues of yeast eEF1A protein. [12] Lys2 is methylated only after trimethylation of Gly1. [12] Yeast eEF1A starts with GKEK-SHINV and is the only known substrate of Efm7, although there are 35 other yeast proteins with aG -K sequence at their Ntermini. [12] Unlike NTMT1/2, Efm7 was not able to methylate the synthetic decamer peptideG KEKSHINVV derived from the Nterminus of eEF1A. [12] Efm7 can methylate domain 1(residues Reviews 1-238) of eEF1A, but to as maller degree of trimethylation. [12] In addition, methylation of eEF1A is increased in the presence of either GDP or GTP,w hichi sk nown to bind to eEF1A and induce conformational changes. [12] These data suggestt hat Efm7 substrate recognition may require the three-dimensional structure, which is different from the classic linear X-P-K/R motif recognition by other eukaryotic protein NTMTs.
Recently,h uman MTase-like protein 13 (METTL13) was identified as ad ual MTase forb oth N-terminal Gly1 and Lys55 of human eEF1A. [13] Humane EF1A contains av ery similarN -terminal sequence, GKEKTHIN,w ith Thr substituted at the fifth position instead of Ser,a ss een in yeast. [12] METTL13h as two distinct MTase domains:N -a nd C-terminald omains that appear to have different recognition preferences. Specifically,t he Cterminal domain is ablet om ethylate peptides derived from the first 15 amino acids of eEF1A, whereas the N-terminal domain is sufficient for methylation of Lys55. [13] Structural alignment of the C-terminal domain of METTL13 with NTMT1 displayed striking differences ( Figure 3B ). So far,e EF1A is the only validated biological substrate for METTL13, although 49 potentials ubstrates were suggested for METTL13. [13] This reflects the high specificity of METTL13 for eEF1A. [13] METTL13i s also called FEAT( faint expression in normal tissues,a berrant overexpression in tumors). As indicated by its alternative name, METTL13/FEATi si mplicated in tumorigenesis in vivo by suppressing apoptosis. [34] FEATwas observed in the cytoplasm, mitochondria, and nucleus of HeLa cells, as well as in the blood of cancer patients. [35] On the other hand, the METTL13/ FEATp rotein was also implied as at umor suppressor in bladder carcinomab yn egatively regulating cell proliferation,m igration, and invasion in bladder cancer cells. [36] 
Substrate recognition
The a-N-terminal methylation has been reportedo nv arious Nterminal sequences in prokaryotic proteins.H owever,a ll identified N-terminalm ethylation on eukaryotic proteins is either a conserved X-P-K/R motif or specific to eEF1A (Table 1) . Thed iscussion herein focuseso ns ubstrate recognitiona nd structure on three humanN TMTs.
Crystal structures of NTMT1-SAH peptides ubstrate ternary complexes reveal that NTMT1c ontains as even-strand b-sheet and five a helixes, which is aR ossmann-fold MTase (Figure 3) . [26, 27] In addition, NTMT1h as two unique structural components:a nN -terminal extension containing three helixes and ap air of b-hairpins. [26] Peptide substrates bind in as imilar manneri nto an egatively chargedc hannel. [26] The first three residues (X-P-K/R) insert into ad efined bindingp ocket,w hich explainst he unique specificity of NTMT1i nm ethylation of the a-N-terminal amine versus the e-amine of Lys. [26] Proteins starting with S/P/A/G-P-K/R have been confirmed to be methylated in vivo. Furthermore, NTMT1 is ablet om ethylate X-P-K/R peptides (X is anya mino acid, except Do rE )i n vitro. [26] Thise xpanded consensus implies that there are about 300 possible substrates for NTMT1. Among them, CENP-A/B, DDB2, PARP3 have subsequently been confirmed (Figure 2) . The tolerance for the first position of the substrate is because of its backboneh ydrogen bond with an Asn168 residue of NTMT1a nd as pacious binding pocket surroundingt he side chain of the first residue X. [10, 11, 26] The importance of Pro2i s revealed by its stacking interaction with Trp136. [11, 26] Pro2 was reported to be replaceable by other residues,i ncluding Ala, Glu, Met, Asn, Gln, Gly, and Ser. [23, 37] However,D ong et al. demonstrated that substitution of Pro2 with Ile, Gln, Glu, or Ser abolished its interaction with NTMT1. [26] Basic residues, including Lys3 or Arg3, are preferred for the peptide substrate, in which electrostatic interactions are formed with key residues Asp177 and Asp180 of NTMT1 (Figure 4) . [10, 26, 37] Mutationo f D180 to lysine abolished the enzyme activity. [26] Cocrystal structures also indicated that NTMT1h ad no significant preference for non-or monomethylated substrates because they had the same orientation to interact with NTMT1. [26] This is consistent with comparable kinetic parameters of NTMT1m ethylation with both substrates, as well as the distributivem echanism of NTMT1methylation. [26, 32, 33] NTMT2 shares ac omparable substrate recognition mode to that of NTMT1. As tructural comparison of the substrate-binding region of NTMT2 with that of NTMT1r evealed as imilars et of residues (Figure 4) . [31] In NTMT2, key substrate-engaging residues are Asn223, Trp191,A sp232, and Asp235, which are in agreement with Asn168, Trp136,A sp177,a nd Asp180 in NTMT1. [26, 31] NTMT2 is able to methylate XPKRIA hexapeptides, [31] althoughi ts physiological substrate has yet to be identified. However,N TMT2e xhibitsadifferent product specificity 
S. cerevisiae X-P-K NTMT1/NRMT1/ Homo sapiens X-P-K/R 2EX4, 5E1B, 5E1M, METTL11A 5E1O, 5E1D, 5E2B, 5E2A,5 CVD, 5CVE NTMT2/NRMT2/ H. sapiens X-P-K/R 5UBB,6 DUB METTL11B Efm7/YLR285W S. cerevisiae GKEKSH METTL13/FEAT H. sapiens GKEKTH 5WCJ Reviews from that of NTMT1. NTMT2 is able to fully methylate G/P-PKRIA, but it predominantly installs onem ethylg roup for other X-PKRIA peptides. [31] Residue Asn89 of NTMT2s erves as a gatekeeper to govern the product specificity. [31] Besidest hose residues involved in substrate binding, multiple mutations have been reported in human cancer samples (Cosmic Catalogue of Somatic Mutationsi nc ancer; https://cancer.sanger.ac.uk/cosmic/). Amongt hem, the N209I endometrial and P211S lung cancer mutants decreased the trimethylation level of RCC1, whereas the Q144H lung cancer mutant increased the trimethylation level of RCC1 with minimal levels of mono-and dimethylated RCC1. [38] For NTMT2, the V224L breastc ancer mutant showedm arginal methylation activity for methylation states. [38] Those data infer that methylation levels may play different roles in different cancers. Meanwhile, it would be worth investigating how those mutationsa ffect the kinetic parameters of the enzyme.
The C-terminal domain of dual MTase METTL13 is responsible for the a-N-terminal methylation of eEF1A. [13] Although yeast Efm7 is not able to methylate the decamerp eptide that is derived from yeast N-terminal eEF1A, METTL13 can methylate the 15-mer peptided erived from humanN -terminal eEF1A.
Ap eptidea rray study suggested an N-terminal consensus sequence [G/A/P]-[K/RF/Y/Q/H]-E-[K/R/Q/I/H/L] for METTL13
, which implies 49 candidate substrates in human proteome. [13] However,o nly peptidec orresponding to the Nterminus of eEF1A was substantially methylated by METTL13t hrough validation. [13] The crystal structure of its core MTase domain (residues 470-699; PDB ID:5 WCJ) in complex with SAH reveals a Rossmann fold-like structure. [13] Ad ockings tudy of the hexamer peptide GKEKTH suggested ah ydrogen bond between the carboxylate Oa tom of Gly1 and side chain of Asn647. [13] Such an interactioni sc onserved in both NTMT1 and -2. [13, 26, 31] However,t he unique interaction of Asp577 with the a-amino group of Gly1 is required for enzymatic activity because the activity of the D577A mutantd ecreasedb yabout half. [13] It is imperative to obtain ac ocrystal structureo fM ETTL13i nc omplex with the eEF1A substrate to elucidatei ts substrate recognition and high specificity for eEF1A. In addition, structurali nformation about full-length METTL13w ould shed light on how both N-and C-terminald omains orient to favor methylation at the a-N terminus and Lys55 of eEF1A, respectively.Awide range of domain movements are speculated to occur to induce conformationalchanges in METTL13.
Functions of a-N-Terminal Methylation
The a-N-terminal amines (pK a = 6-8) are less basic in comparison with the side chain aliphatic amines (pK a % 10.5). Consequently, methylation of a-N terminus alters not only the hydrophobicity and steric hindrance, but also charge state under the physiological condition. Early reported N-terminal methylated proteins such as myosin light chain LC-1, histone H2B, and cytochrome c-557 are involved in large macromolecular complexes. [39] Therefore, protein N-terminal methylation has been proposed to regulate protein-protein interactions in complex macromolecular structures. N-terminal methylation was also suggested to be involved in protein stability since methylation interplays with another predominant acetylation at the Nterminus. Additionally,H ershko et al. demonstrated that af ree a-N-amineg roup is required for ubiquitin-mediated protein degradationi nc omparison with chemical methylated protein. [40] The relevance of a-N-terminal methylation in protein-DNA interactions has been unveiled in interactions of RCC1 and CENP-A/B with chromatin, and DDB2 with DNA damage foci. [21, 23, 24, 41] In addition, the level of a-N-terminal methylation increases in response to av ariety of extracellular stimuli, including increased cell density,h eat shock, and arsenitet reatment; [20, 24] thus suggesting itsp otentiala sanew epigenetic mark.
Functions of methylated proline
Me 2 Pro was presenti nt he relativelyf ree-moving N-terminal regiono fC. oncopelti cytochrome c557 as an ovel N-terminal protein modification. [42] The observation of only one CaHr esonance of Me 2 Pro at d = 4.03 ppm in the NMRs pectrum suggestedt hat dimethylation might limit the rate of interconversion between cis and trans conformations. [43] Thus, relatively rigid Me 2 Pro could yield specific folding for the interaction with other partners, including proteins andD NA. The occurrence of Me 2 Pro wasa lso found in starfish histone H2B. The Nterminalm ethylation of yeast 26S proteasome subunit Rpt1 (starts with Pro-Pro-Lys) is involved in cell growth or stress tolerance to oxidant and canavanine stress. [19] Heat shock and arsenite treatments induced ar apid increase in Me 2 Pro of histone H2B and as hift of methylation sites of H3 in D. melanogaster,w hich correlated with chromatin remodeling and gene inactivation. [44] The N-terminal endofH 2B was inferred to interactp referentially with DNA rather than histone, [44] which suggested that this methylationc ould regulate both proteinprotein and protein-DNAi nteractions.
Functions of methylated alanine
Accumulating evidence revealed the widespread occurrence of a-N-Me 3 Ala in ah ighly mobile N-terminal region (about4 0r esidues)o fm yosin alkali 1( A1) and LC2 light chains in vertebrate striated skeletal and cardiacm uscles. [6] The disappearance of the NMR signal for N-methyl protons of Me 3 Ala in the presence of actin implied its role in the interaction of the myosin light chain with the C-terminal region of actin. [6, 43] Such interactions are weakened by increased ionics trength, [6, 43] which suggests the involvement of electrostatic interactions in this case. Hayashibaraa nd Miyanishid emonstrated that the positively charged a-N-Me 3 Ala was criticalf or the actin-A1 interaction because it loweredb oth V max and K M of the actin-activated ATPase activity of the globularh ead of myosin A1. [45] Such interaction results in ah igher binding affinity for myosin to actin and as lower turnoverr ate of actin-activated ATPase activity. [45] Hence, trimethylation of Ala1 may have as uppressive effect on mobility between actin andm yosin filaments.
Meanwhile, trimethylationo fA la1 can have ap ositive effect on DNA damage repair.D DB2 possesses an N-terminal se- quenceo fA la-Pro-Lys, which undergoes a-N-methylation, with trimethylation being the predominant form. [23] DDB2r ecruits DDB1-CUL4A-based E3 ligase to initiate the DNA repair process. The a-helical N-terminal domain (102 residue) of DDB2i s important to mediate interactions with DDB1 and damaged DNA. [46] a-N-Methylated DDB2 enhances its nuclear localization, recruitment to cyclobutene pyrimidine dimers, and ATMa ctivation;t hus indicating the functiono fN -terminal methylation in UV-damagedD NA repair. [23] 3.3. Functions of methylated serine RCC1 is pivotali nr egulating nucleart ransport, mitotic spindle formation, and nuclear envelope assembly through its dynamic association with chromatin. [47] Chen et al. identified that a-Nterminal methylation of the first Ser residue was important for RCC1 interacting with chromosomes, which was critical for mitotic spindle assembly and function. [21, 48] In addition, RCC1 mutant K3Q or knockdown of NTMT1 abolished N-terminal methylation of RCC1 and led to multipolar spindle formation and mitotic defects. [21] Further studies by Hao and Macara revealed that a-N-methylationm ight enhance the association of RCC1 with chromatin through electrostatic interactions with DNA. [49] Hitakomate et al. provideds trong support for the importanceo fa na-N-methylated tail for stable association of RCC1 with interphase chromatin. [50] 
Functions of methylated glycine
Humanc entromere playsa ne ssential role in chromosome segregation to ensure genome stability.T rimethylation of Gly has ap ositive effect on the functions of both CENP-A and -B proteins. CENP-A,acentromere-specific histoneH 3v ariant, contains an N-terminal Gly-Pro-Arg motif, which is subjectt oa-Nmethylation in cells. [25] This methylation is independento f other posttranslational modifications of the CENP-A tail. [25] CENP-A replaces H3 in centromeric nucleosomes and is indispensablef or recruitment and assemblyo fs ome components to the centromere and kinetochore. [51] The N-terminal tail of CENP-A was proposed to direct proper deposition of CENP-B at centromeres and stabilizei ts binding to centromeres through direct interaction. [52] a-N-Trimethylation is implied to be essential for CENP-A in maintaining chromosome segregation fidelity because methylation of CENP-Ai sr equired for cell survival, localization of CENP-T and CENP-I, and formation of the bipolars pindle. [41] Loss of CENP-A methylation causedd efects in chromosomes egregation and cell death in the presence of p53. Methylation in CENP-Ad emonstratedd ifferent effects in the absence of p53, [41] which suggested al ink between p53 and a-N-methylation.
CENP-B contains an N-terminal DNA-binding domain that binds specifically to a1 7-bp CENP-B box in centromeric a-satellite DNA, andaC-terminald imerization domain. Interaction of the CENP-B box with DNA supports faithful chromosome segregation through direct interaction with CENP-A and CENP-C. [53] CENP-B possesses aGly-Pro-Lys sequence at its Nterminus and it is primarily trimethylated in cellsu nder stressed conditions. The a-N-trimethylation of chromatin-bound CENP-B is predominant and increases the binding of CENP-B to the centromeric DNA. [24] 
Mechanism and Inhibitors
Protein MTases generally promote an ucleophilic substitution reaction to transfer am ethyl group from cofactor SAM to their substrates. NTMT1w as proposed to follow ac ommon S N 2r eaction mechanism. [26, 27] NTMT1-catalyzed methylation follows a random sequential Bi Bi mechanism, which involves the formation of at ernary complex with either substrate binding to NTMT1f irst. [32] Twoh ighly conserved Asp180 and His140 act as general bases to facilitate deprotonation of the a-aminog roup of the Nterminus to attack SAM to transfer the methyl group. [26] MutantH 140A lost the catalytic activity,b ut retained binding affinity to the peptides ubstrate. [26] NTMT1 is known to be at rimethylase that catalyzes mono-, di-, and trimethylation. [32, 33] During the process of multiple methylations, the substrate can be released and rebind to NTMT1, which proceeds through ad istributivem echanism for multiple methylations. [32, 33] The biological significances of NTMT1i nc ell mitosis, chromatin segregation, and damaged DNA repair,a long with its implications in cancer and aging, have stimulated interest in discovering NTMT1 inhibitors. Potent and specific inhibitors are critical top robe the functiono fe ach individual protein. Bisubstrate analoguest hat simultaneously target both binding sites are proven to be an effective strategy to obtain potent and selectivei nhibitors for many enzymes with two binding sites. [54] [55] [56] Because NTMT1 forms at ernary complex during catalysis,abisubstrate strategy has been appliedt od esign and synthesize bisubstrate inhibitors by covalently linking aS AM analogue with ap eptide substrate to mimic the transition state. [57, 58] NTMT1 bisubstrate inhibitors contain three components:a nN-adenosyl-l-methionine (NAM)t hat replaces the sulfonium iono fS AM with an itrogen atom, ah exapeptide derived from the N-terminal sequence of NTMT1 substrate, and al inker (Scheme 2). Compound NAM-TZ-SPKRIA (IC 50 = (0.81 AE 0.13) mm)c ontains at riazole linker andi ncorporatesa SPKRIA peptide derived from the Nterminus of RCC1, whereas NAM-C3-GPRRRS (IC 50 = 0.94 AE 0.16 mm)l inks aG PKRRSp eptide derived from CENP-A through ap ropylene group. [57, 58] NAM-TZ-SPKRIAs howedl ess than 50 %i nhibition against PKMT G9a and PRMT1at50mm. [57] NAM-C3-GPRRRS showednosignificant inhibition at 30 mm against either G9a or PRMT1. [58] Kinetic analysisr evealed that inhibitor NAM-TZ-SPKRIA engagedw ith both substrate binding sites. [57] The potency of such bisubstrate inhibitors corroborate the Bi Bi mechanism of NTMT1 methylation. Despite the stability and cellular permeability of the above bisubstrate inhibitors, they provideafoundation to discovers mall-molecule inhibitors for NTMT1.
Gaps and Opportunities in Protein a-N-Terminal Methylation
Evolutionary conservation of N-methylation and the recognition motif of NTMT are low.Itremains apuzzle whether cellular N-terminal methylation plays differing roles in different organisms or if similarf unctionsa re exerted throughd ifferent pathways. Recognition motifs of centromere-relatedh uman substrates of NTMT1, including RCC1 and CENP-A/B, are retained in mammals, but are missing in lower organisms. [27] Ther ecognition sequence of histone 2B protein for N-terminal methylation is conserved from protozoans to insects, but not in mammals. [27] For example, human H2B is eightr esidues longert han tetrahymena H2B, which masks the APKK motif.
Althougha nX -P-K/R motif search suggested about 300 proteins that mayu ndergo a-N-terminal methylation, profiling a full spectrum of physiological protein substrates would shed light on pathways mediated by a-N-terminal methylation. Despite an increased number of reports on a-N-terminal methylation roles, the functions of N-terminal methylation are still underexplored for those validated NTMT1 protein substrates, including the tumor suppressor RB1 and oncoproteinS ET.M eanwhile, no recognition motif has been identified to read protein N-terminal methylation. Revealing the molecular basis for recognizing a-N-terminal methylation could benefit the discovery of a-N-terminal methylation functions, as well as potential therapeutic applications involving a-N-terminal methylation in cancer and aging.
The reversibility of a-N-methylationi ss till under debate. Lys methylation used to be believed to be irreversible, but the discovery of histonedemethylases, including lysine-specific demethylase 1a nd jmjc domain-containinge nzymes,d emonstrate the dynamic character of histonem ethylation. Therefore, it is rational toh ypothesize that a-N-terminal methylation might be reversible as well. Although predominant N-terminal acetylation has led to ab elief of the interplay between N-terminal methylation and acetylation, rarea cetylation of the X-P-K/R motif with Pro at the second positionf avors the likelihood of reversibility.F uture studies are neededt od etermine if a-N-terminal methylation is reversible.
Besides the specific X-P-K/R recognition motif of a-N-terminal methylation in eukaryotes, the new discovery of N-terminal methylation on eEF1A demonstrates acompletely different recognition preference. This shifts our curiosity to question if there are any extra a-N-terminal methylation sites and/orw riters. In summary,t he identification of possible new writers, readers, and erasersw ould be important to illuminate the comprehensive function and regulation of the a-N-terminal methylation network. Finally,cell-potent and druglike inhibitors are required for the NTMT family to enablet he research community to reveal their physiological and pharmacological functions.
